Skip to main content
Nature Communications logoLink to Nature Communications
. 2023 Sep 21;14:5865. doi: 10.1038/s41467-023-41662-3

Author Correction: Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma

Andrew Patterson 1,2, Noam Auslander 2,
PMCID: PMC10514182  PMID: 37735162

Correction to: Nature Communications 10.1038/s41467-022-32838-4, published online 19 September 2022

The original version of this article contained an error in Fig. 2E, in which the labels on the x-axis of “Leukocyte proliferation regulation” and “T cell proliferation regulation” were inadvertently swapped. This has been corrected in both the PDF and HTML versions of the article.

The original version of the Supplementary Information associated with this article contained an error in Supplementary Fig. 3B, in which the labels on the x-axis of “Leukocyte proliferation regulation” and “T cell proliferation regulation” were inadvertently swapped. The HTML has been updated to include a corrected version of the Supplementary Information.

Supplementary information

Supplementary information

The online version contains supplementary material available at 10.1038/s41467-023-41662-3.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials


Articles from Nature Communications are provided here courtesy of Nature Publishing Group

RESOURCES